Related references
Note: Only part of the references are listed.Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics
Kendall S. Frazier et al.
TOXICOLOGIC PATHOLOGY (2015)
Species-specific Inflammatory Responses as a Primary Component for the Development of Glomerular Lesions in Mice and Monkeys Following Chronic Administration of a Second-generation Antisense Oligonucleotide
Kendall S. Frazier et al.
TOXICOLOGIC PATHOLOGY (2014)
Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future
Igor Mikaelian et al.
TOXICOLOGIC PATHOLOGY (2014)
Translation Strategy for the Qualification of Drug-induced Vascular Injury Biomarkers
Kaidre Bendjama et al.
TOXICOLOGIC PATHOLOGY (2014)
Formation, Clearance, Deposition, Pathogenicity, and Identification of Biopharmaceutical-related Immune Complexes: Review and Case Studies
Jennifer L. Rojko et al.
TOXICOLOGIC PATHOLOGY (2014)
Mechanistic Understanding for the Greater Sensitivity of Monkeys to Antisense Oligonucleotide-Mediated Complement Activation Compared with Humans
Lijiang Shen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Recent insights into C3 glomerulopathy
Thomas D. Barbour et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Regulatory Forum Opinion Piece*: Differences between Protein-based Biologic Products (Biotherapeutics) and Chemical Entities (Small Molecules) of Relevance to the Toxicologic Pathologist
Michael W. Leach
TOXICOLOGIC PATHOLOGY (2013)
Preclinical Evaluation of the Toxicological Effects of a Novel Constrained Ethyl Modified Antisense Compound Targeting Signal Transducer and Activator of Transcription 3 in Mice and Cynomolgus Monkeys
Sebastien A. Burel et al.
NUCLEIC ACID THERAPEUTICS (2013)
International Harmonization of Toxicologic Pathology Nomenclature: An Overview and Review of Basic Principles
Peter C. Mann et al.
TOXICOLOGIC PATHOLOGY (2012)
Histopathology of Incidental Findings in Cynomolgus Monkeys (Macaca Fascicularis) Used in Toxicity Studies
Junko Sato et al.
JOURNAL OF TOXICOLOGIC PATHOLOGY (2012)
Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response
Sebastien A. Burel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis
Paul A. Monach et al.
ARTHRITIS AND RHEUMATISM (2011)
Potential candidate genomic biomarkers of drug induced vascular injury in the rat
Deidre A. Dalmas et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2011)
CpG-ODNs induces up-regulated expression of chemokine CCL9 in mouse macrophages and microglia
C. Ravindran et al.
CELLULAR IMMUNOLOGY (2010)
Newly Identified CpG ODNs, M5-30 and M6-395, Stimulate Mouse Immune Cells to Secrete TNF-α and Enhance Th1-Mediated Immunity
Sun-Shim Choi et al.
JOURNAL OF MICROBIOLOGY (2010)
Spontaneous Findings in the Heart of Mauritian-Origin Cynomolgus Macaques (Macaca fascicularis)
Justin D. Vidal et al.
TOXICOLOGIC PATHOLOGY (2010)
Blood Cytokines as Biomarkers of In Vivo Toxicity in Preclinical Safety Assessment: Considerations for Their Use
Jacqueline M. Tarrant
TOXICOLOGICAL SCIENCES (2010)
Crosstalk pathways between Toll-like receptors and the complement system
George Hajishengallis et al.
TRENDS IN IMMUNOLOGY (2010)
Stimulation of the Immune System by Therapeutic Antisense Oligodeoxynucleotides and Small Interfering RNAs via Nucleic Acid Receptors How to Avoid Immune Activation
Denise Richardt-Pargmann et al.
OLIGONUCLEOTIDE THERAPEUTICS (2009)
Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
Rafael Ponce et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2009)
Biomarkers in Peripheral Blood Associated with Vascular Injury in Sprague-Dawley Rats Treated with the Phosphodiesterase IV Inhibitors SCH 351591 or SCH 534385
James L. Weaver et al.
TOXICOLOGIC PATHOLOGY (2008)
Transcriptional Profiling of Laser Capture Microdissected Rat Arterial Elements: Fenoldopam-induced Vascular Toxicity as a Model System
Deidre A. Dalmas et al.
TOXICOLOGIC PATHOLOGY (2008)
Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
B Demeule et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2006)
Biomarkers and mechanisms of drug-induced vascular injury in non-rodents
C Louden et al.
TOXICOLOGIC PATHOLOGY (2006)
Spontaneous lesions of the cardiovascular system in purpose-bred laboratory nonhuman primates
Ronnie Chamanza et al.
TOXICOLOGIC PATHOLOGY (2006)
Non-CpG-containing antisense 2′-methoxyethyl oligonucleotides activate a proinflammatory response independent of toll-like receptor 9 or myeloid differentiation factor 88
JJ Senn et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Drug-induced vascular injury - a quest for biomarkers
W Kerns et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Spontaneous and drug-induced hepatic pathology of the laboratory Beagle dog, the cynomolgus macaque and the marmoset
JR Foster
TOXICOLOGIC PATHOLOGY (2005)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration
M Heikenwalder et al.
NATURE MEDICINE (2004)
Polyarteritis Nodosa in a cynomolgus macaque (Macaca fascicularis)
BF Porter et al.
VETERINARY PATHOLOGY (2003)
The origin of cynomolgus monkey affects the outcome of kidney allografts under Neoral immunosuppression
K Menninger et al.
TRANSPLANTATION PROCEEDINGS (2002)
Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide
SP Henry et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2002)
Share Paper
